Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial
Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.

Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page
- Check6 days agoChange DetectedAccess to the study record now shows a 403 Forbidden page with a Home button, replacing the previous study details. This indicates a site access restriction rather than a change to the study information.SummaryDifference19%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor site update rather than changes to study content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision label has been updated to v3.6.5, indicating a minor metadata update. There are no evident changes to the study details or content.SummaryDifference17%

- Check55 days agoChange DetectedAdded a citation for Longer-Term Efficacy and Safety of Zodasiran in Patients with Mixed Hyperlipidaemia to the Publications section. This links ARCHES-2 to recent literature on the drug's long-term efficacy and safety.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a site update. This change does not modify the study details or related information.SummaryDifference0.1%

- Check70 days agoChange DetectedNo additions or deletions were identified in the provided changes data. The page content remains as previously listed in the study record and related sections.SummaryDifference0.0%

Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.